HL20: Bruce Bodaken—Survival and the Need for Continuous Change
The Blue Shield that Bodaken is leaving is quite different from the struggling insurer he took over in 2000. That company had around one million members and made its payroll by pulling money out of its limited surplus funds. "It simply wasn't going to survive," he explains.
Today the insurer is a dominant player in the California market. Membership has tripled, its surplus has grown to billions of dollars, and the company is on solid financial ground.
When asked to name his biggest accomplishments Bodaken points to the company's journey toward helping to make sure everyone has access to affordable healthcare, including prevention and wellness services. "All of us have a responsibility to be a part of the system and we need to make a way for those who can't afford to get care," he states.
And he is pleased with the results the 2% pledge has produced so far. Over the years Blue Shield has been roundly criticized for its steep rate hikes and when the pledge was announced, it was greeted with a healthy dose of skepticism by just about everyone. But in 2011, the company paid out around $475 million, including $450 million to members, $20 million to help provider groups form accountable care organizations, and $5 million to the Blue Shield Foundation and community grants.
- The Secret to Physician Engagement? It's Not Better Pay
- Two-Midnight Rule Must be Fixed or Replaced, Say Providers
- Don't Underestimate Emotional Intelligence
- Yale New Haven Health Partners with Tenet Healthcare in CT
- Care Coordination Tough to Define, Measure
- 4 Reasons PCMH Principles Aren't Going Away
- Size Matters in Antibiotic Overuse
- Evidence-Based Practice and Nursing Research: Avoiding Confusion
- CDC Warns of Antibiotic Overuse in Hospitals
- SCOTUS Review of NC Board Case 'A Very Big Deal' to Providers